Skip to main content
. 2016 Feb 26;7(13):16517–16528. doi: 10.18632/oncotarget.7760

Figure 1. Carfilzomib potentiates CUDC-101-induced anti-ATC effects in 8505c cells.

Figure 1

Images were captured using a bright-field, time-lapse microscopy imaging system at the indicated times after adding vehicle control, carfilzomib (6 nM), CUDC-101 (0.8 μM), or carfilzomib (6 nM) and CUDC-101 (0.8 μM).